Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.

Peter MandlSelma TobudicHelmut HaslacherThomas KaronitschDaniel MrakThomas NothnaglThomas PerkmannHelga RadnerJudith SautnerElisabeth SimaderFlorian WinklerHeinz BurgmannDaniel AletahaStefan WinklerStephan Blüml

Published in: Annals of the rheumatic diseases (2022)

Patients with SARD showed a good response after the second vaccination with an mRNA vaccine. However, the choice of immunosuppressive medication has a marked effect on both SCR and overall antibody level, and the number of different immunomodulatory therapies determines vaccination response.

Keyphrases

sars cov
rheumatoid arthritis
healthcare
multiple sclerosis
emergency department
drug induced
adverse drug